December 23, 2021 (Reuters) – The U.S. on Thursday authorized Merck & Co’s (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a …
December 23, 2021 (Reuters) – The U.S. on Thursday authorized Merck & Co’s (MRK.N) antiviral pill for COVID-19 for certain high-risk adult patients, a …
Lorem ipsum dolor sit amet, consect etur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept